This HTML5 document contains 241 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://dx.doi.org/10.1038/
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
n13https://scigraph.springernature.com/pub.10.1038/
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q34030791
rdf:type
wikibase:Item
schema:description
artículo científico publicado en 2014 научна статия articol științific 2014年論文 2014年论文 2014년 논문 سائنسی مضمون artykuł naukowy ২০১৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ vedecký článok 2014年の論文 artigo científico (publicado na 2014) bilimsel makale 2014年论文 artigo científico научни чланак наукова стаття, опублікована в серпні 2014 article scientifique (publié 2014) tieteellinen artikkeli 2014年論文 مقالهٔ علمی mokslinis straipsnis wissenschaftlicher Artikel 2014年论文 videnskabelig artikel (udgivet 2014) artículu científicu espublizáu en 2014 bài báo khoa học научная статья מאמר מדעי article científic 2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած 2014年論文 επιστημονικό άρθρο 2014年论文 บทความทางวิทยาศาสตร์ artikull shkencor научни чланак 2014 թվականի օգոստոսին հրատարակված գիտական հոդված мақолаи илмӣ teaduslik artikkel مقالة علمية tudományos cikk scientific article 2014年论文 naučni članak vitskapeleg artikkel 2014 nî lūn-bûn artigo científico (publicado na 2014) 2014年论文 мақолаи илмӣ scienca artikolo vědecký článek vitenskapelig artikkel vetenskaplig artikel wetenschappelijk artikel სამეცნიერო სტატია 2014年論文 article scientific articolo scientifico artikulong pang-agham 2014年論文
p:P577
wds:Q34030791-27AC41FE-8E8D-4143-A06B-5DAF5335C542
wdt:P577
2014-08-12T00:00:00Z
p:P407
wds:Q34030791-D49FC4FF-9BD6-4377-BB76-29A0890E8C01
wdt:P407
wd:Q1860
p:P2888
wds:Q34030791-FAF34197-CF60-4CA1-9C25-D0260FDA9488
wdt:P2888
n13:srep06031
p:P2860
wds:Q34030791-01A224A0-90EF-4C03-A108-F7391839511C wds:Q34030791-0540419C-F011-4F7A-AAC0-3193991EE9EE wds:Q34030791-07C9BD58-8AE7-4E6A-8F60-CBE0390B71A1 wds:Q34030791-0DF07B43-55A4-48B0-8CB6-0E54E14997EA wds:Q34030791-0E12401A-E0B6-471F-AF49-0463B502E152 wds:Q34030791-0FCB4AD8-E135-4B35-82DA-444FDFAB249B wds:Q34030791-14A7D358-9B64-4D95-8D6E-6E63DCCE23CA wds:Q34030791-157DE194-4042-4865-8612-9B9C0FD52117 wds:Q34030791-17C5D5EF-A8D3-4E5C-8517-10B8E84B221D wds:Q34030791-FE92E2F1-7CDC-46EF-AA1E-71B3C5BB1747 wds:Q34030791-FEC6103D-8EF7-46B9-A55D-30BD6EF8D4E9 wds:Q34030791-51F95AA6-DDFB-4037-8412-5E83FB33F772 wds:Q34030791-5944992A-411B-48F6-9680-052CB2659920 wds:Q34030791-64388879-BFE4-45AD-B1CC-E7E4549E2794 wds:Q34030791-651D95FE-3625-4C39-92FE-30254EC3DDC9 wds:Q34030791-6E8D423A-D43C-41E1-8326-6A4A4063FE0F wds:Q34030791-6ECE5DB9-41AC-4882-90C8-1CD971569298 wds:Q34030791-7B478145-FBCA-40D5-B16D-6E356E80D8A0 wds:Q34030791-7FA18F60-11D5-4FC0-BE42-63BBCFF88C2A wds:Q34030791-813C417E-19A6-4A9F-9493-5890C33F9140 wds:Q34030791-8A002A5D-92BC-4208-AE70-95983851E0E8 wds:Q34030791-8E3C8106-5678-4898-B980-841EC8502C52 wds:Q34030791-1F1EA5C9-5EAD-4CBB-8A23-49A7685CC63F wds:Q34030791-2B30F12C-6CC1-43AE-8A70-8F1C92B43E8E wds:Q34030791-3460A71F-5784-49D9-B119-7AAEA47A7715 wds:Q34030791-359788E2-813A-4B83-BE2C-18101D10BD94 wds:Q34030791-389B113B-53B6-4FD7-B32E-993A2B95F94A wds:Q34030791-3A1523DA-2B46-46F8-B970-9257FF7D42D3 wds:Q34030791-3BE6D866-698A-42E3-8586-1ADC9D74307C wds:Q34030791-3C983365-50FA-4C67-B230-DA3025F2E33B wds:Q34030791-48E0495D-2B58-4E58-A743-1357E28FA54A wds:Q34030791-4C3AE9E3-4CF4-4F4C-9BE6-6E12CD544215 wds:Q34030791-CD549405-6DFC-4FEF-9408-606D9B935DF8 wds:Q34030791-D309DB42-72C4-43EB-AAE9-0254F7E7DA11 wds:Q34030791-D6F7BE17-4DC9-4B24-AC40-01263C2AAF30 wds:Q34030791-D78F6948-6161-41F9-AF29-207765639204 wds:Q34030791-DBE34708-5B70-4121-A954-62F5B18AEE0A wds:Q34030791-DF420804-8A3C-45D2-8399-DEDB1B2192C7 wds:Q34030791-E8F565EB-704F-42D9-B54B-A8795DED5B5A wds:Q34030791-EC18D4B8-1A8B-4913-9311-0F6F3572F945 wds:Q34030791-ECFC1CC4-BE54-44EA-A86A-B367E75C4D44 wds:Q34030791-F1885098-2C7A-4DC9-ACA7-C114F3A03B90 wds:Q34030791-F51E33FA-095D-4953-AC8C-57298D6E9D7E wds:Q34030791-90A9BCAC-C825-4B06-8863-C5123EA563A6 wds:Q34030791-9667AFD1-0A28-4608-9C5C-695F26EE67DB wds:Q34030791-A826B866-A06D-4773-AFFE-3C30113C5DAF wds:Q34030791-A853F417-00E2-46E7-A056-99A740B63F39 wds:Q34030791-B454A132-79F2-4788-BE2D-F5B8DF0C750C wds:Q34030791-B46BFB57-20F8-41B7-AAA6-A27529A74E40 wds:Q34030791-BDE90EAE-53E0-4792-804C-10275E652399
wdt:P2860
wd:Q36701590 wd:Q73677814 wd:Q44285254 wd:Q35036728 wd:Q37832021 wd:Q34355711 wd:Q33308472 wd:Q27860595 wd:Q40406706 wd:Q29614601 wd:Q40023447 wd:Q22252312 wd:Q33495790 wd:Q33780701 wd:Q36278239 wd:Q35622038 wd:Q29547302 wd:Q36489757 wd:Q45857630 wd:Q27860504 wd:Q44106085 wd:Q36178164 wd:Q43077944 wd:Q27860947 wd:Q28248642 wd:Q37435425 wd:Q34729610 wd:Q39421427 wd:Q73441800 wd:Q34932327 wd:Q34712853 wd:Q38312556 wd:Q95784569 wd:Q39521060 wd:Q34220084 wd:Q28251373 wd:Q24311900 wd:Q40416582 wd:Q52507969 wd:Q33787400 wd:Q29617585 wd:Q28131776 wd:Q34611616 wd:Q35640098 wd:Q36147972 wd:Q34876083 wd:Q28385231 wd:Q39534138 wd:Q28538542 wd:Q28535457
p:P2093
wds:Q34030791-A4578A81-C35F-4113-8796-4D16880B88E0 wds:Q34030791-A662C21B-2533-4C46-9571-8F31765CE9B5 wds:Q34030791-A24E5881-8BCC-4695-B4C2-D91E0AE8717B wds:Q34030791-C78629D7-DF23-45D3-98DE-E356B20F4B07 wds:Q34030791-B7E27415-B4D5-437B-BDD6-7E16DCA23238 wds:Q34030791-BB3CBA02-845F-4EDF-A518-7F2AFB735263 wds:Q34030791-CBD68DE5-3823-4228-9908-C9DFD2788FDB wds:Q34030791-F7A0D9B4-8880-4981-B768-70E32B232130 wds:Q34030791-F05F226D-8CE4-43AB-9577-816090F24D9D wds:Q34030791-36342D8A-101C-4B5A-BC1A-AA5AA582DDB0 wds:Q34030791-403F721C-C535-40E5-8407-75B02E097A9B wds:Q34030791-397E60D4-A63A-4298-9C5B-668C4450246E wds:Q34030791-6D1D045D-D82E-4F71-B67F-A7BB3D04E042 wds:Q34030791-82D5A057-A4B3-4D9C-8C86-EA3411EDE468 wds:Q34030791-04117A82-9EE2-4F9C-B51C-FC07C29EADD2 wds:Q34030791-00D4C883-94BD-4001-995B-894CA7A987B7 wds:Q34030791-10FC4AAD-D4D7-4AB5-9FFC-60406A3FD03F wds:Q34030791-113E9DD4-626E-4856-998A-1B76C0BD40A5
wdt:P2093
Xuejiao Song Guobo Li Youzhi Xu Luoting Yu Yong Xia Hongjun Lin Shuang Zhang Youli Pan Li Liu Yuquan Wei Jun Zeng Yongxia Zhu Qian Lei Yinglan Zhao Tinghong Ye Senyi Deng Deliang Li Nana Meng
rdfs:label
YLT192, a novel, orally active bioavailable inhibitor of VEGFR2 signaling with potent antiangiogenic activity and antitumor efficacy in preclinical models YLT192, a novel, orally active bioavailable inhibitor of VEGFR2 signaling with potent antiangiogenic activity and antitumor efficacy in preclinical models YLT192, a novel, orally active bioavailable inhibitor of VEGFR2 signaling with potent antiangiogenic activity and antitumor efficacy in preclinical models
skos:prefLabel
YLT192, a novel, orally active bioavailable inhibitor of VEGFR2 signaling with potent antiangiogenic activity and antitumor efficacy in preclinical models YLT192, a novel, orally active bioavailable inhibitor of VEGFR2 signaling with potent antiangiogenic activity and antitumor efficacy in preclinical models YLT192, a novel, orally active bioavailable inhibitor of VEGFR2 signaling with potent antiangiogenic activity and antitumor efficacy in preclinical models
schema:name
YLT192, a novel, orally active bioavailable inhibitor of VEGFR2 signaling with potent antiangiogenic activity and antitumor efficacy in preclinical models YLT192, a novel, orally active bioavailable inhibitor of VEGFR2 signaling with potent antiangiogenic activity and antitumor efficacy in preclinical models YLT192, a novel, orally active bioavailable inhibitor of VEGFR2 signaling with potent antiangiogenic activity and antitumor efficacy in preclinical models
p:P1476
wds:Q34030791-5B4D4471-063E-4950-9F67-1F7B013B26D2
wdt:P1476
YLT192, a novel, orally active bioavailable inhibitor of VEGFR2 signaling with potent antiangiogenic activity and antitumor efficacy in preclinical models
p:P304
wds:Q34030791-55031351-5EAB-4DE3-BF01-20D541BF721C
wdt:P304
6031
p:P31
wds:Q34030791-C87F42ED-FDFB-4C71-B524-E081CEA50CCB
wdt:P31
wd:Q13442814
p:P921
wds:Q34030791-44EADA0C-8D6B-4F34-98FD-4BC9C15AB48C
wdt:P921
wd:Q574834
p:P698
wds:Q34030791-C75782DF-6020-4D66-8C84-BF65F53EC844
wdtn:P698
n12:25112436
wdt:P698
25112436
p:P1433
wds:Q34030791-4D0BCC5E-7003-4666-B7AA-5BCA797F310F
wdt:P1433
wd:Q2261792
p:P478
wds:Q34030791-08876F6D-A227-48F5-8808-3BE1576B1F36
wdt:P478
4
p:P356
wds:Q34030791-CAECD84E-B2C0-495C-BDE8-93CDEFFA9116
wdtn:P356
n11:SREP06031
wdt:P356
10.1038/SREP06031
p:P275
wds:Q34030791-a3ae339c-195b-49f0-a1a8-96e8e546e75b
p:P6216
wds:Q34030791-28c78e05-d6d0-4a89-a48f-68ad479bded7
wdt:P275
wd:Q20007257
wdt:P6216
wd:Q50423863
p:P5875
wds:Q34030791-1B38B3B3-568C-4058-A211-89161D6CD1BB
wdt:P5875
264745868
p:P6179
wds:Q34030791-967DF055-ECC3-463F-B300-16E6BCCED92A
wdt:P6179
1039494278
p:P932
wds:Q34030791-FBB4ACD2-A10A-4EB3-AEC0-7520EFA1FB2B
wdt:P932
4129416